Sadahisa Ogasawara
机构：Chiba University · ORCID：0000-0002-6540-9064
发表论文 346 篇 · 总被引 13058 次 · h-index 39
代表论文
- Atezolizumab Plus Bevacizumab for TACE ‐Unsuitable Intermediate‐Stage HCC Beyond Up‐To‐7 Criteria: Final Analysis of REPLACEMENT (2025 · Liver International · 被引 3)
- Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma (2025 · Cellular Signalling · 被引 1)
- Clinical Outcomes After Failed Endoscopic Detorsion for Sigmoid Volvulus: A Single‐Center Retrospective Cohort Study (2026 · DEN Open)
- Immune-related liver injury: Clinical and histological subtyping defines distinct trajectories and therapeutic implications (2026 · Research Square)
- Data from Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study (2026)
- Supplementary Table S1 from Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study (2026)